- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-06-0001421

Chevron Pharma Private Limited
About Chevron Pharma Private Limited
Data last updated:
Chevron Pharma Private Limited is a private limited company based in Ankleshwar, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2010PTC061749. Its GSTIN is 24AAECC0898H1ZM (Gujarat).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹45 Lakh. It is led by directors including Harshaben Mahesh Jakasaniya and Umesh Mavjibhai Mendapara.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6505 GIDC Estate, Ankleshwar, Gujarat, India – 392001.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.69 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹54.6 Lakh (net margin 5.6%) and EBITDA of ₹1.49 Cr (EBITDA margin 15.4%). Revenue has declined at a compounded annual rate (CAGR) of 28% over three years and 15% over five years.
The company has about 57 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹13.94 Cr on record.
Chevron Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0001421). The current compliance status is marked as compliant by the Registrar of Companies.
Recognitions & Rankings of Chevron Pharma
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address6505 GIDC Estate, Ankleshwar, Gujarat, India – 392001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Chevron Pharma Private Limited
The main business activity of Chevron Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Chevron Pharma Private Limited FY 2025 filings available
Chevron Pharma Private Limited reported revenue of ₹9.69 Cr (up 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Chevron Pharma Private Limited
Revenue rose 33% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 15%. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Chevron Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.49 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹54.6 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Chevron Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Chevron Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Chevron Pharma Private Limited
Chevron Pharma has 6 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harshaben Mahesh Jakasaniya | Director | 01 May 2019 | 7 Years 5 Months | Current |
| Umesh Mavjibhai Mendapara Also directs: Amsal-Chem Private Limited, Apex Healthcare Limited, Mendas Pharma Private Limited and 3 more | Director | 28 Dec 2010 | 15 Years 9 Months | Current |
| Karan Maheshkumar Jakasaniya | Director | 19 Mar 2018 | 8 Years 7 Months | Current |
| Pravin Samatbhai Teraiya | Director | 28 Dec 2010 | 15 Years 9 Months | Current |
| Uramilaben Pravinbhai Teraiya | Director | 28 Dec 2010 | 15 Years 9 Months | Current |
| Rameshbhai Devjibhai Gabani Also directs: Amsal-Chem Private Limited, Apex Healthcare Limited, Ankleshwar Research and Analytical Infrastructure Association and 1 more | Director | 27 Jul 2010 | 16 Years 2 Months | Current |
Peer Comparison of Chevron Pharma Private Limited
Chevron Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Akisab Trading Limited | ₹9.73 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Mumbai, Maharashtra, India |
| Shree Radhey Gobind International Pharmaceuticals Private Limited | ₹9.73 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Delhi, India |
| Labinduss Limited | ₹9.73 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Palghat, Kerala, India |
| Renspur Health Care Private Limited | ₹9.71 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Hyderabad, Telangana, India |
| Harson Laboratories India Private Limited | ₹9.71 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Vadodara, Gujarat, India |
| Chevron Pharma Private Limited this company | ₹9.69 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Ankleshwar, Gujarat, India |
| Uni-Labs (India) Private Limited | ₹9.68 Cr (FY 2024) | •••• | •••• | -8.0% | •••• | Tamil Nadu, India |
| Coterie Healthcare India Private Limited | ₹9.67 Cr (FY 2025) | •••• | •••• | 103.0% | •••• | New Delhi, Delhi, India |
| Adikan Healthcare Private Limited | ₹9.65 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Patna, Bihar, India |
| Prabhat Chemiorganics Limited | ₹9.65 Cr (FY 2025) | •••• | •••• | 48.0% | •••• | Dahisar, Mumbai-68, Maharashtra, India |
| Salvavita Pharmaceuticals Private Limited | ₹9.64 Cr (FY 2024) | •••• | •••• | 206290.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Chevron Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Chevron Pharma Private Limited
Chevron Pharma Private Limited is audited by K K HARYANI & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K K HARYANI & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Chevron Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Chevron Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 May 2018 | Axis Bank Limited | ₹4.72 Cr | Satisfied |
| 06 Mar 2018 | Axis Bank Limited | ₹4.72 Cr | Satisfied |
| 08 Jun 2015 | Bank of Baroda | ₹1.5 Cr | Satisfied |
| 13 Mar 2015 | Bank of Baroda | ₹1.5 Cr | Satisfied |
| 02 Aug 2011 | Axis Bank Limited | ₹1.5 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Chevron Pharma Private Limited
Chevron Pharma Private Limited has a workforce of 57 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Chevron Pharma Private Limited
Chevron Pharma Private Limited has 11 board changes on record since 2010: 6 appointments and 5 cessations. The latest: Harshaben Mahesh Jakasaniya was appointed as Director on 01 May 2019.
14 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Chevron Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Chevron Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Chevron Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Chevron Pharma Private Limited
Chevron Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECC0898H1ZM | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Chevron Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chevron Pharma Private Limited
Chevron Pharma is an active private limited company based in Ankleshwar, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 July 2010 (16+ years old) and is registered under CIN U24100GJ2010PTC061749.
Chevron Pharma reported revenue of ₹9.69 Cr for FY 2025 (up 33% YoY).
Chevron Pharma has 6 current directors:
- Harshaben Mahesh Jakasaniya - Director
- Umesh Mavjibhai Mendapara - Director
- Karan Maheshkumar Jakasaniya - Director
- Pravin Samatbhai Teraiya - Director
- Uramilaben Pravinbhai Teraiya - Director
- Rameshbhai Devjibhai Gabani - Director
Chevron Pharma reported a net profit of ₹54.6 Lakh (net margin 5.6%) and EBITDA of ₹1.49 Cr (EBITDA margin 15.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Chevron Pharma is -28% over three years and -15% over five years. In the latest year (FY 2025) revenue rose 33%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Chevron Pharma is 24AAECC0898H1ZM, registered in Gujarat.
The CIN (Corporate Identification Number) of Chevron Pharma is U24100GJ2010PTC061749. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chevron Pharma was incorporated on 27 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Chevron Pharma by revenue are Akisab Trading Limited, Shree Radhey Gobind International Pharmaceuticals Private Limited, Labinduss Limited, Renspur Health Care Private Limited, Harson Laboratories India Private Limited and 5 more, all in the Pharma industry (Formulations).
Harshaben Mahesh Jakasaniya was appointed as Director on 01 May 2019. Maheshkumar Rugnathbhai Jakasaniya ceased to be Director on 14 Apr 2019. Karan Maheshkumar Jakasaniya was appointed as Director on 19 Mar 2018. Chevron Pharma has 11 board changes on record in total.
Yes, Chevron Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-06-0001421).